
The FDA took the unusual step to ask Endo Pharmaceutical to voluntarily withdraw its opioid painkiller, Opana ER, from the …
Endo Pharmaceuticals has said that current supply restrictions for its new Opana ER formulation of oxymorphone are likely to be …
Cytomos appoints life sciences executive to board
Scots neonatal innovations target hearing loss and earlier care

